← All organizations
Highest phase reached
Phase 4
Timeline
1940s
- Jan 1, 1942
Daewoong Pharmaceutical Co. LTD.— Founded
2010s
- May 30, 2015
HanAll BioPharma Co., Ltd.— Acquired - Dec 18, 2015
meropenem— Marketing Organization
Drugs by trial phase (137 distinct, 197 trials)
Phase 4 (29 own, 3 via acquisition)
Phase 3 (28 own, 4 via acquisition)
Phase 2 (8 own, 2 via acquisition)
Phase 1 (56 own, 5 via acquisition)
Indications
Studied for
- Alzheimer Disease
- Arthritis
- Arthritis, Rheumatoid
- Blepharospasm
- Cardiovascular Diseases
- Coronary Artery Disease
- Coronary Disease
- Coronavirus Infections
- Diabetes Mellitus
- Diabetes Mellitus, Type 2
- Diabetic Foot
- Dry Eye Syndromes
- Dwarfism, Pituitary
- Dyslipidemias
- Dyspepsia
- Endocrine System Diseases
- Epidermolysis Bullosa
- Epidermolysis Bullosa Dystrophica
- Esophagitis
- Fatigue
- Foot Ulcer
- Gallstones
- Gastritis
- Gastritis, Atrophic
- Gastroesophageal Reflux
- Heart Diseases
- Hepatitis
- Hepatitis A
- Hepatitis B
- Hepatitis B, Chronic
- Hyperlipidemias
- Hyperlipoproteinemias
- Hypertension
- Hypertrophy
- Irritable Bowel Syndrome
- Keratoconjunctivitis Sicca
- Lung Diseases, Obstructive
- Malnutrition
- Mucositis
- Muscle Spasticity
- Myocardial Ischemia
- Neuralgia
- Neuralgia, Postherpetic
- Obesity
- Prostatic Neoplasms
- Puberty, Precocious
- Pulmonary Disease, Chronic Obstructive
- Schizophrenia
- Severe Acute Respiratory Syndrome
- Stomach Neoplasms
- Stomatitis
- Stroke
- Syndrome
- Ulcer
Marketed drugs (1)
Subsidiaries (1 direct, 1 total across the full acquisition tree)
Recent trials (50)
- NCT07267221Lead sponsorPhase 1Dec 1, 2025
- NCT07213310Lead sponsorPhase 1Nov 30, 2025
- NCT07260851Lead sponsorPhase 1Nov 5, 2025
- NCT07144176Lead sponsorPhase 1Sep 30, 2025
- NCT07013279Lead sponsorPhase 3Jul 15, 2025
- NCT07096921CollaboratorN/AJul 8, 2025
- NCT06782139CollaboratorPhase 4Jan 20, 2025
- NCT06682000Lead sponsorPhase 3Jan 1, 2025
- NCT06671392Lead sponsorPhase 3Dec 31, 2024
- NCT06736587Lead sponsorPhase 1Dec 10, 2024
- NCT06644404Lead sponsorPhase 1Oct 26, 2024
- NCT06606093Lead sponsorPhase 3Sep 23, 2024
- NCT06437951Lead sponsorPhase 1Jul 31, 2024
- NCT06751121Lead sponsorPhase 3Feb 6, 2024
- NCT06399835CollaboratorPhase 4Feb 1, 2024
Details
- Founded
- Seoul, KR Jan 1, 1942
- Last known activity
- Dec 1, 2025